BCM
DORM icon

Bayesian Capital Management’s Dorman Products DORM Stock Holding History

Bayesian Capital Management’s Portfolio DORM Stock Details DORM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,203
Closed -$285K – 699
2024
Q4 		$285K Buy
+2,203
New +$282K 0.03% 489

Other funds holding DORM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bayesian Capital Management's DORM Position: Q1 2025 in Review

Bayesian Capital Management sold out of Dorman Products (DORM) in Q1 2025, closing a stake of 2,203 shares — an estimated $285K sold.

Bayesian Capital Management first reported a position in DORM in Q4 2024 and held it in 1 quarter. The position peaked at $285K in Q4 2024. 345 funds tracked by Wall St. Rank hold DORM as of Q1 2025.

  • Bayesian Capital Management reported no remaining Dorman Products position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,203 Dorman Products shares in Q1 2025, an estimated $285K.
  • Bayesian Capital Management first reported a position in Dorman Products in Q4 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Dorman Products position peaked at $285K in Q4 2024.
  • 345 funds tracked by Wall St. Rank held Dorman Products as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.